跳轉至內容
Merck
  • Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract.

Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract.

Laboratory investigation; a journal of technical methods and pathology (1985-04-01)
M Miettinen, V P Lehto, D Dahl, I Virtanen
摘要

Twelve cases of gastrointestinal neuroendocrine tumors, including eight carcinoids and four pancreatic islet cell tumors or their metastases, were immunohistochemically analyzed for the expression of different types of intermediate filament proteins. All of the tumors showed cytokeratin positivity in immunostaining, and the Western blotting technique revealed 45- and 52-kilodalton cytokeratins in carcinoid tumors. Three of the islet cell tumors, but none of the carcinoid tumors, showed, in addition, varying numbers of neurofilament-positive tumor cells when evaluated with rabbit and mouse monoclonal antineurofilament antibodies. The presence of only the 70-kilodalton neurofilament and cytokeratin polypeptides in an islet cell tumor was revealed also by using the Western blotting technique. On the other hand, both fetal and adult pancreatic islet cells showed only cytokeratin positivity. Neurofilament-positive epithelial cells were not found in normal small intestines either. The results show epithelial characteristics in normal gastrointestinal neuroendocrine cells and neuroendocrine tumors by their expression of cytokeratin. In addition, some islet cell tumors display the 70-kilodalton neurofilament protein which suggests the acquisition of a new type of intermediate filament during the neoplastic change.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
Neurofilament (2F11) Mouse Monoclonal Antibody
Sigma-Aldrich
Neurofilament (EP79) Rabbit Monoclonal Primary Antibody